Growing community of inventors

Sint-Katelijne-Waver, Belgium

Oliver Lenz

Average Co-Inventor Count = 5.03

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 67

Oliver LenzPierre Jean-Marie Bernard Raboisson (7 patents)Oliver LenzKenneth Simmen (7 patents)Oliver LenzTse-I Lin (7 patents)Oliver LenzDominique Louis Nestor Ghislain Surleraux (6 patents)Oliver LenzSarvajit Chakravarty (1 patent)Oliver LenzBarry Patrick Hart (1 patent)Oliver LenzKenneth Alan Simmen (0 patent)Oliver LenzOliver Lenz (7 patents)Pierre Jean-Marie Bernard RaboissonPierre Jean-Marie Bernard Raboisson (178 patents)Kenneth SimmenKenneth Simmen (26 patents)Tse-I LinTse-I Lin (11 patents)Dominique Louis Nestor Ghislain SurlerauxDominique Louis Nestor Ghislain Surleraux (32 patents)Sarvajit ChakravartySarvajit Chakravarty (87 patents)Barry Patrick HartBarry Patrick Hart (10 patents)Kenneth Alan SimmenKenneth Alan Simmen (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Janssen Sciences Ireland Uc (4 from 111 patents)

2. Tibotec Pharmaceuticals Ltd. (2 from 66 patents)

3. Tibotec-virco Virology Bvba (1 from 2 patents)

4. Janssen R&d Ireland (45 patents)


7 patents:

1. 9987277 - Carboxamide 4-[(4-pyridyl)amino] pryimidines for the treatment of hepatitis C

2. 9951075 - Pteridines useful as HCV inhibitors and methods for the preparation thereof

3. 9708328 - Pteridines useful as HCV inhibitors and methods for the preparation thereof

4. 9290502 - Pteridines useful as HCV inhibitors and methods for the preparation thereof

5. 8030318 - Fused bicyclic inhibitors of HCV

6. 8022077 - Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof

7. 7977342 - HCV inhibiting bi-cyclic pyrimidines

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/26/2025
Loading…